- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02171247
Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)
July 28, 2014 updated by: Duke University
Comparison of the Use of High Iodine Concentration Contrast Material (Isovue 370) vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)
Computed Tomography Angiogram (CTA) scans are performed routinely to look at the vessels in the body as an alternative to directly injecting contrast into the vessels and taking pictures.
Different types of intravenous (into the vein, IV) contrast are available to fill the vessels and make them easier to see.
The purpose of the study is to determine the best type of contrast for this scan.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adult patients who are referred for coronary CTA for suspected or known coronary artery disease
Exclusion Criteria:
- creatinine greater than 2.0
- allergy to contrast media
- patients under the age of 18
- women who are pregnant or breast feeding
- patients with cardiac arrhythmia will also be excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Isovue 370
Isovue 370 is a contrast agent with increased iodine concentration.
|
Isovue 370 is a contrast agent with increased iodine concentration.
|
|
Active Comparator: Visipaque 320
Standard protocol is Visipaque 320.
|
Visipaque 320 is standard protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Contrast to Noise Ratio
Time Frame: during scan, approximately 3 hours
|
Contrast-to-noise ratios (CNRs) were calculated as follows: CNR = (vascular attenuation - myocardium attenuation) / SD of mean noise attenuation.
|
during scan, approximately 3 hours
|
|
Image Quality
Time Frame: during scan, approximately 3 hours
|
Depiction of Branch Vessels - coronary branch depiction was performed as consensus decisions of two blinded radiologists.
Criteria used was abscence or presence of vessels.
|
during scan, approximately 3 hours
|
|
Motion Artifact
Time Frame: during scan, approximately 3 hours
|
The outcome will be measured by individual scores.
The scores from multiple readers will be averaged.
|
during scan, approximately 3 hours
|
|
Attenuation of the Ascending Aorta and Coronary Arteries
Time Frame: during scan, approximately 3 hours
|
The investigator will measure the length of visualized coronary artery for the left anterior descending, left circumflex and right coronary arteries as a way of quantifying visualization of distal coronary segments.
|
during scan, approximately 3 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Daniel T Boll, MD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2008
Primary Completion (Actual)
December 1, 2010
Study Completion (Actual)
December 1, 2010
Study Registration Dates
First Submitted
June 12, 2014
First Submitted That Met QC Criteria
June 20, 2014
First Posted (Estimate)
June 24, 2014
Study Record Updates
Last Update Posted (Estimate)
August 15, 2014
Last Update Submitted That Met QC Criteria
July 28, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- Pro00004492
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Computed Tomographic Angiography
-
Peking Union Medical College HospitalBayerNot yet recruitingCoronary Artery Disease | Coronary Computed Tomographic Angiography
-
Mahidol UniversityRecruitingHeart Rate | Coronary Computed Tomography AngiographyThailand
-
Karolinska University HospitalRecruitingCardiac Output | Contrast Media | Coronary Computed Tomography AngiographySweden
-
GE HealthcareUniversity of WashingtonRecruitingCardiac Catheterization | Myocardial Infarction (MI) | Coronary Computed Tomographic AngiographyUnited States
-
The First Affiliated Hospital with Nanjing Medical...CompletedOptical Coherence Tomography (OCT) | Percutaneous Coronary Intervention (PCI) | Single-Photon Emission Computed Tomography (SPECT) | Coronary Angiography (CAG) | Borderline Coronary Artery LesionsChina
-
BayerCompletedMultidetector Computed Tomography | AngiographyChina
-
Jordan Collaborating Cardiology GroupNot yet recruitingComputed Tomography | Coronary Angiography | Incidental FindingsJordan
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
University of GalwayScience Foundation IrelandRecruitingMyocardial Ischemia | Biomarkers | Lipoprotein(a) | Coronary Artery Disease (CAD) | Atheroscleroses, Coronary | Computed Tomography Angiography | AI (Artificial Intelligence)Ireland
-
Centro Cardiologico MonzinoPolitecnico di Milano; Fondazione IRCCS Policlinico San Matteo di Pavia; Scientific...RecruitingCoronary Artery Disease | Coronary Computed Tomography AngiographyItaly
Clinical Trials on Isovue 370
-
Bracco Diagnostics, IncCompleted
-
Bracco Diagnostics, IncTerminated
-
Bracco Diagnostics, IncCompleted
-
Bracco Diagnostics, IncCompleted
-
Duke UniversityCompleted
-
Rush University Medical CenterCompletedLumbar Degenerative Disc Disease | Lumbar Degenerative Disease | Degenerative SpineUnited States
-
Ectin Research ABWithdrawnMetastatic Urothelial CancerSweden
-
Seoul National University HospitalCompleted
-
Bracco Diagnostics, IncCompleted
-
GE Healthcarei3 StatprobeCompleted